中图分类号：
R969
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] JIANG Y.1 case report of allergic shock caused by Zhengqinfengtongning . Yunnan J Tradit Chin Med Mater Med(云南中医中药杂志),1996, 17(2):27.
[2] HE X M. Intramuscular injection of Zhengqingfengtongning Injection allergic shock l cases. China J Chin Mater Med(中国中药杂志), 1998, 23(7):435.
[3] CHE J M, XU X D.1 case of severe allergic reactions caused by Zhengqinfengtongning.Strait Pharm J(海峡药学),1996,8(3):52.
[4] HUANG J Z. 1 case of allergic shock induced by the injection of Zhengqingfengtongning Injection. J Med Theor Pract,2007,20(2):127.
[5] GUO L H.1 case of allergic shock caused by Zhengqingfengtongning. J Yunnan Univ Tradit Chin Med (云南中医学院学报),1996,19(2):34.
[6] LI R.1 case of allergic shock induced by the injection of Zhengqingfengtongning Injection. Chin Hosp Pharm J(中国医院药学杂志),1997,17(6):284.
[7] JIE L G, SHEN Y, SUN W F, et al. The effect of Zhengqingfengtongning Injection into sacroiliac joint on patients with ankylosing spondylitis. J Emerg Tradit Chin Med(中国中医急症), 2009,18(9): 1429-1450.
[8] GOU L Y, ZHENG H B, FENG H. Treatment of knee osteoarthritis by intra-articular injection of Zhengqingfengtongning in 158 cases. J Guangxi Tradit Chin Med Univ(广西中医学院学报),2007,10(1):37-38.
[9] ZHAO L W, SUN J Q. Zhengqingfengtongning knee joint cavity injection treatment of 78 cases of rheumatoid arthritis.Chin J Conval Med(中国疗养医学),2011,20(11):1015-1016.
XIA L, LI L, XU B S, et al. Zhengqingfengtongning articular cavity injection treatment of rheumatoid arthritist. Nat Med Front China(中国医疗前沿),2008,3(23):16-17.
CHEN J J, ZHANG Y P. Zhengqingfengtongning articular cavity injection clinical observation on treatment of rheumatoid arthritis.Nei Mongol J Tradit Chin Med(内蒙古中医药),2011,5(5):21-22.
XIA D Q, YANG J H. Zhengqingfengtongning sequential treatment of 35 cases of hip osteoarthritis. Henan Tradit Chin Med(河南中医), 2009,29(8):818-819.
FENG H, GOU L Y, XU P F. Zhengqingfengtongning injection in the treatment of infrapatellar fat pad strain on 110 cases bed observation.Guangxi Med J(广西医学),2010,32(5):577-578.
YANG Y X, YI J S. Zhengqinfengtongning Injection in treatment of arthralgia syndrome: clinical observation of 66 cases. Guid J Tradit Chin Med Pharm (中医药导报),2006,12(3):25-26.
WANG N, HUANG Z S, LI Y. Zhengqinfengtongning Injection transdermal medicine for treating 40 cases of knee joint synovitis. Tradit Chin Med Res(中医研究),2014,27(3):16-18.
ZHAO Y M, WANG X Z, HE X L, et al. Observation on the degree of joint swelling of the joints of the spine by the method of ion introduction of the injection of Zhengqinfengtongning Injection. Chin Med Mod Dist Edu China (中国中医药现代远程教育),2010,8(13):189-190.
ZHANG X M, LIU J. Clinical analysis of treating 60 cases of knee arthritis with Zhengqinfengtongning. J Jiujiang Univ(Nat Sci)(九江学院学报:自然科学版),2008,23(3):32-33.
CAI X H, WANG S, CHEN B A. Research advance on the pharmacological effects of Tetrandrine. Chin J Nat Med,2011,9(6):473-480.
NOMURA M, YAMAZAKI R, TAKAYA M, et al. Inhibition of tetrandrine on epidermal growth factor-induced cell transformation and its signal transduction. Anticancer Res, 2007,27(5):3187-3193.
LI Y, LI P, LIN S, et al. Paeonol inhibited TNF-alpha-induced GM-CSF expression in fibroblast-like synoviocytes.Int J Clin Pharmacol Ther, 2014,52(11):986-996.
KIM S H, KIM S A, PARK M K, et al. Paeonol inhibits anaphylactic reaction by regulating histamine and TNF-α.Int Immuno Pharmacol, 2004,4(2):279-287.
BI G Y, LIU C H, XU J, et al. Amount of proteinuria in GC joint Zhengqinfengtongning treatment of IgA nephropathy in 24 cases of clinical observation. Guid J Tradit Chin Med Pharm (中医药导报), 2013,19(5):52-53.
CICCARELLI F, DE MARTINIS M, GINALDI L. Glucocorticoids in patients with rheumatic diseases: friends or enemies of bone?. Curr Med Chem,2015,22(5):596-603.
LIANG Y, LU Y L. Analysis of 159 cases of traditional Chinese medicine injection adverse reaction. Chin J Pharmacov (中国药物警戒),2008,5(5):288-303.
YU J Q, HUANG Y M. Zhengqinfengtongning pharmacological research. Hunan J Tradit Chin Med (湖南中医杂志),1994,10(3):54-55.
MA C J, FU J H, TONG X M. Zhengqinfengtongning induced acute myelocytic lack in 2 cases. Zhejiang Med J(浙江医学),2000,22(7):448.
WANG H, XU J, LIU J J. Analysis of 226 cases of traditional Chinese medicine injection adverse reaction report. Chin J Pharmacov (中国药物警戒),2011,8(10):621-623.
FU S X, ZHANG S S, LI Y S, et al. The pharmacological effects of sinomenine Ⅱ. Toxicity and pharmacological in general. Acta Pharm Sin(药学学报),1963,10(11):673-676.
HUI X, XU K, DOU J J, et al. Sinomenine transfer body percutaneous drug pharmacokinetic and pharmacodynamic studies. Chin Pharm J(中国药学杂志),2011,46(5):374-377.
STATE FOOD AND DRUG SUPERVISION AND ADMINISTRATION BUREAU. National adverse drug reaction monitoring annual report (2013). Chin J Drug Eval(中国药物评价),2014,31(4):254-256.
CHEN T B, LI D, CHOU P, et al. Headspace gas chromatography with electron capture detector method of determination of the residues of chloroform in Zhengqinfengtongning preparation raw material. Chin J Pharm Anal (药物分析杂志),2015,35(9):1645-1648.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
江苏省中医药领军人才项目(LJ200907)
{{custom_fund}}
PDF(1051 KB)
